[go: up one dir, main page]

SE7900380L - Anisamidderivat - Google Patents

Anisamidderivat

Info

Publication number
SE7900380L
SE7900380L SE7900380A SE7900380A SE7900380L SE 7900380 L SE7900380 L SE 7900380L SE 7900380 A SE7900380 A SE 7900380A SE 7900380 A SE7900380 A SE 7900380A SE 7900380 L SE7900380 L SE 7900380L
Authority
SE
Sweden
Prior art keywords
aniside
derivatives
aniside derivatives
Prior art date
Application number
SE7900380A
Other languages
English (en)
Other versions
SE448874B (sv
Inventor
M Thominet
J Acher
J-C Monier
Original Assignee
Ile De France
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ile De France filed Critical Ile De France
Publication of SE7900380L publication Critical patent/SE7900380L/sv
Publication of SE448874B publication Critical patent/SE448874B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE7900380A 1978-01-20 1979-01-16 Derivat av 4-amino-5-alkylsulfonyl-orto-anisamider, farmakologisk komposition och sett att framstella amiderna SE448874B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7801632A FR2415099A1 (fr) 1978-01-20 1978-01-20 Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes

Publications (2)

Publication Number Publication Date
SE7900380L true SE7900380L (sv) 1979-07-21
SE448874B SE448874B (sv) 1987-03-23

Family

ID=9203689

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7900380A SE448874B (sv) 1978-01-20 1979-01-16 Derivat av 4-amino-5-alkylsulfonyl-orto-anisamider, farmakologisk komposition och sett att framstella amiderna
SE8603773A SE460968B (sv) 1978-01-20 1986-09-09 Mellanfoerening, till framstaellning av terapeutiskt anvaendbara derivat av 4-amino-5-alkylsulfonyl-orto-anisamider, vilken utgoeres av 2-metoxi-4-amino-5-alkyltio- eller 2-metoxi-4-amino-5-alkylsulfonylbensoesyra

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8603773A SE460968B (sv) 1978-01-20 1986-09-09 Mellanfoerening, till framstaellning av terapeutiskt anvaendbara derivat av 4-amino-5-alkylsulfonyl-orto-anisamider, vilken utgoeres av 2-metoxi-4-amino-5-alkyltio- eller 2-metoxi-4-amino-5-alkylsulfonylbensoesyra

Country Status (42)

Country Link
US (2) US4294828A (sv)
JP (1) JPS6049192B2 (sv)
AR (2) AR221354A1 (sv)
AT (1) AT377977B (sv)
AU (1) AU528561B2 (sv)
BE (1) BE872585A (sv)
BG (2) BG31497A3 (sv)
CA (1) CA1101430A (sv)
CH (1) CH637927A5 (sv)
CS (1) CS226181B2 (sv)
CY (1) CY1201A (sv)
DD (1) DD141520A5 (sv)
DE (1) DE2901181C2 (sv)
DK (1) DK158346C (sv)
EG (1) EG14045A (sv)
ES (2) ES476755A1 (sv)
FI (1) FI71126C (sv)
FR (1) FR2415099A1 (sv)
GB (2) GB2083458B (sv)
GR (1) GR64431B (sv)
HK (1) HK12184A (sv)
HU (1) HU179793B (sv)
IE (1) IE47798B1 (sv)
IL (1) IL56411A (sv)
IN (1) IN150226B (sv)
IT (1) IT1164655B (sv)
LU (1) LU80786A1 (sv)
MC (1) MC1232A1 (sv)
MX (2) MX5793E (sv)
NL (1) NL191707C (sv)
NO (1) NO151320C (sv)
NZ (1) NZ189378A (sv)
OA (1) OA06156A (sv)
PH (2) PH15725A (sv)
PL (2) PL116532B1 (sv)
PT (1) PT69068A (sv)
RO (2) RO80311A (sv)
SE (2) SE448874B (sv)
SU (1) SU820659A3 (sv)
YU (2) YU42172B (sv)
ZA (1) ZA79219B (sv)
ZM (1) ZM579A1 (sv)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
NZ199080A (en) * 1980-12-12 1984-07-31 Beecham Group Ltd 2-alkoxy-4-amino-5-alkylsulphonyl-n-(3beta-(8-hydrocarbyl-8-azabicyclo (3,2,1)octyl))benzamides
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
FR2584401B1 (fr) * 1985-07-04 1987-11-20 Ile De France Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique
US5227388A (en) * 1989-12-26 1993-07-13 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
US5260319A (en) * 1989-12-26 1993-11-09 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
FR2678266A1 (fr) * 1991-06-28 1992-12-31 Delagrange Laboratoires Nouveaux derives de 2-hydroxy 4-amino 5-ethylsulfonyl benzamide utiles comme anxiolytiques.
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
FR2753376B1 (fr) * 1996-09-18 1998-10-16 Synthelabo Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
AU2004237951A1 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with GABA modulators, anticonvulsants or benzodiazapines
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
EP1753460A2 (en) * 2004-05-11 2007-02-21 Pfizer Products Inc. Combination of atypical antipsychotics and 5-ht1b receptor antagonists
PE20061318A1 (es) * 2005-04-22 2006-12-28 Wyeth Corp Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de trastornos psicoticos
EP1889198B1 (en) 2005-04-28 2014-11-26 Proteus Digital Health, Inc. Pharma-informatics system
CA2663377A1 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US7825156B2 (en) * 2007-02-02 2010-11-02 Copharms Method of treating bipolar depression with a benzamide derivative
WO2009156889A1 (en) * 2008-06-25 2009-12-30 Pfizer Inc. Diaryl compounds and uses thereof
US20100105755A1 (en) * 2008-09-12 2010-04-29 Auspex Pharmaceuticals, Inc. Substituted benzamide modulators of dopamine receptor
DK3395372T3 (da) 2009-02-20 2022-04-19 Enhanx Biopharm Inc System til afgivelse af glutathion-baseret medikament
EP4218718A3 (en) 2009-05-06 2024-04-24 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
CN101898991B (zh) * 2009-05-31 2013-09-25 江苏天士力帝益药业有限公司 一种(s)(-)-氨磺必利d-(-)-酒石酸盐的合成方法
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法
GB201004020D0 (en) 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
AU2016216578B2 (en) * 2010-03-11 2017-11-23 Acacia Pharma Limited The use of amisulpride as an anti-emetic
AU2014202535B2 (en) * 2010-03-11 2016-05-26 Acacia Pharma Limited The use of amisulpride as an anti-emetic
WO2011158084A1 (en) 2010-06-17 2011-12-22 Lupin Limited An improved process for preparation of amisulpride
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103304453A (zh) * 2013-06-18 2013-09-18 苏州诚和医药化学有限公司 两步法合成2-甲氧基-4-氨基-5-乙砜基苯甲酸
CN103319384A (zh) * 2013-06-18 2013-09-25 苏州诚和医药化学有限公司 制备2-甲氧基-4-氨基-5-乙砜基苯甲酸的方法
CN103450058B (zh) * 2013-09-18 2015-10-14 广安凯特医药化工有限公司 一种氨磺必利酸的制备方法
CN104725292B (zh) * 2015-03-23 2017-07-25 湖北荆江源制药股份有限公司 一种(s)(‑)‑氨磺必利的制备方法
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
US11377421B2 (en) 2016-11-28 2022-07-05 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
AU2017364899B2 (en) 2016-11-28 2023-07-06 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
CN106995397B (zh) * 2016-12-12 2020-01-14 河北医科大学 R-氨磺必利药用盐、制备方法、晶型及其用途
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method
AU2018379992B2 (en) 2017-12-05 2022-07-21 Sunovion Pharmaceuticals Inc. Nonracemic mixtures and uses thereof
AU2018378348B2 (en) 2017-12-05 2024-09-19 Sunovion Pharmaceuticals Inc. Crystal forms and production methods thereof
CN110790693A (zh) * 2018-08-02 2020-02-14 北京万全德众医药生物技术有限公司 一种(s)(-)-氨磺必利的制备方法
PH12021553056A1 (en) 2019-06-04 2023-09-11 Sunovion Pharmaceuticals Inc Modified release formulations and uses thereof
USD1047552S1 (en) * 2021-04-23 2024-10-22 Krueger International, Inc. Furniture leg with frame
CN116003304A (zh) * 2023-02-08 2023-04-25 浙江皓华制药有限公司 一种氨磺必利的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR2313935A1 (fr) * 1975-06-10 1977-01-07 Ile De France Nouveaux benzamides substitues, leurs derives et leur procede de preparation
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (sv) * 1973-09-25 1980-06-27 Ile De France
FR2299862B1 (en) * 1975-02-07 1978-07-21 Soc Et Scient Et Ind Substd. N-(1-benzylpyrrolidinyl-2-alkyl)benzamides - used as antiemetics, anti-ulcer agents and CNS active
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
DE2556457C3 (de) * 1974-12-18 1981-02-12 Synthelabo S.A., Paris N-(Pyrrolidin-2-yl-methyl)-2-methoxybenzamide, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
PT69068A (fr) 1979-02-01
IE47798B1 (en) 1984-06-27
SU820659A3 (ru) 1981-04-07
ES476755A1 (es) 1979-06-01
ZM579A1 (en) 1979-12-21
NL191707C (nl) 1996-04-02
PH22287A (en) 1988-07-22
RO80311A (ro) 1982-12-06
CH637927A5 (fr) 1983-08-31
NO151320C (no) 1985-04-17
AU528561B2 (en) 1983-05-05
YU25483A (en) 1983-10-31
AR220574A1 (es) 1980-11-14
NO790180L (no) 1979-07-23
PL212899A1 (sv) 1980-01-14
PL116532B1 (en) 1981-06-30
SE460968B (sv) 1989-12-11
LU80786A1 (fr) 1979-09-07
JPS54145658A (en) 1979-11-14
NL7900457A (nl) 1979-07-24
IT1164655B (it) 1987-04-15
YU41278B (en) 1986-12-31
FR2415099A1 (fr) 1979-08-17
BE872585A (fr) 1979-06-07
IT7947706A0 (it) 1979-01-18
HK12184A (en) 1984-02-24
ZA79219B (en) 1980-01-30
CS226181B2 (en) 1984-03-19
GB2083458A (en) 1982-03-24
SE8603773D0 (sv) 1986-09-09
ES477782A1 (es) 1979-09-16
AU4337379A (en) 1979-07-26
FI790182A7 (fi) 1979-07-21
DK158346B (da) 1990-05-07
FR2415099B1 (sv) 1981-02-20
DE2901181A1 (de) 1979-07-26
DD141520A5 (de) 1980-05-07
NL191707B (nl) 1995-12-01
CY1201A (en) 1983-12-31
ATA39879A (de) 1983-12-15
GB2012765B (en) 1982-09-08
DK158346C (da) 1990-10-08
PL118151B1 (en) 1981-09-30
HU179793B (en) 1982-12-28
SE448874B (sv) 1987-03-23
AR221354A1 (es) 1981-01-30
CA1101430A (en) 1981-05-19
BG31496A3 (bg) 1982-01-15
JPS6049192B2 (ja) 1985-10-31
MX7623E (es) 1990-03-27
AT377977B (de) 1985-05-28
US4401822A (en) 1983-08-30
FI71126C (fi) 1986-11-24
MC1232A1 (fr) 1979-10-26
RO76393A (ro) 1981-03-30
PH15725A (en) 1983-03-18
GB2083458B (en) 1983-03-09
FI71126B (fi) 1986-08-14
GB2012765A (en) 1979-08-01
GR64431B (en) 1980-03-21
YU42172B (en) 1988-06-30
DE2901181C2 (de) 1984-07-19
NZ189378A (en) 1983-03-15
IL56411A (en) 1982-09-30
IN150226B (sv) 1982-08-21
IL56411A0 (en) 1979-03-12
YU5079A (en) 1983-06-30
SE8603773L (sv) 1986-09-09
DK20979A (da) 1979-07-21
OA06156A (fr) 1981-06-30
US4294828A (en) 1981-10-13
EG14045A (en) 1983-09-30
MX5793E (es) 1984-07-19
NO151320B (no) 1984-12-10
IE790092L (en) 1979-07-20
BG31497A3 (bg) 1982-01-15

Similar Documents

Publication Publication Date Title
SE7907493L (sv) Anilinokinazolinderivat
SE7900380L (sv) Anisamidderivat
FI790486A7 (fi) Aminosocker-derivat
FI791081A7 (fi) Tioetiansyraderivat
AT379079B (de) Akupunkturgeraet
AT370950B (de) Hoeschenwindel
BE872071A (fr) Afdichtorgaan
AT365922B (de) Netzbett
MC1257A1 (fr) Derive pyrrolidinique
ATA196579A (de) Sportschuh
FI794027A7 (fi) Ketal- och tioketalderivat av merkaptoacyl-prolin
MC1258A1 (fr) Derives pyrrolidiniques
AR218561A1 (es) Copoliester p-oxibenzoilico
ATA872778A (de) Uhrband
DK143979A (da) Chromanonderivater
FI65785B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara sustituerade steroid-spiro-oxazolidinon-derivat
BE874488A (fr) Derives benzylideniques
AT368010B (de) Rollskier
ATA26879A (de) B-ettbank
DK149809C (da) 1-alkylsubstituerede pyrazolderivater
FI790091A7 (fi) Foerfarande foer framstaellning av ergotpeptidalkaloidderivat
SE7800821L (sv) Rennugn
DE2966658D1 (de) Oxadiazolotriazine derivatives
LU80991A1 (fr) Derives aminoaldehydiques
DK327079A (da) Phenoxybutanderivater

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7900380-2

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 7900380-2

Format of ref document f/p: F